These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2032667)
1. Urinary excretion of benzoylecgonine following ingestion of Health Inca Tea. Jackson GF; Saady JJ; Poklis A Forensic Sci Int; 1991; 49(1):57-64. PubMed ID: 2032667 [TBL] [Abstract][Full Text] [Related]
2. Identification and quantitation of alkaloids in coca tea. Jenkins AJ; Llosa T; Montoya I; Cone EJ Forensic Sci Int; 1996 Feb; 77(3):179-89. PubMed ID: 8819993 [TBL] [Abstract][Full Text] [Related]
3. Validity testing of the TDx Cocaine Metabolite Assay with human specimens obtained after intravenous cocaine administration. Cone EJ; Menchen SL; Mitchell J Forensic Sci Int; 1988 Jun; 37(4):265-75. PubMed ID: 3410396 [TBL] [Abstract][Full Text] [Related]
5. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991 [TBL] [Abstract][Full Text] [Related]
7. Cocaine and benzoylecgonine excretion in humans. Hamilton HE; Wallace JE; Shimek EL; Land P; Harris SC; Christenson JG J Forensic Sci; 1977 Oct; 22(4):697-707. PubMed ID: 370332 [TBL] [Abstract][Full Text] [Related]
8. Routine detection of benzoylecgonine in urine at a sensitivity of 35 ng/mL by a combination of EMIT and gas chromatography/mass spectrometry. Joern WA J Anal Toxicol; 1987; 11(3):110-2. PubMed ID: 3298855 [TBL] [Abstract][Full Text] [Related]
9. Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite. Cone EJ; Yousefnejad D; Dickerson SL J Forensic Sci; 1990 Jul; 35(4):786-91. PubMed ID: 2202774 [TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of immunologically reactive metabolite(s) after intranasal administration of cocaine, as followed by enzyme immunoassay. Van Dyke C; Byck R; Barash PG; Jatlow P Clin Chem; 1977 Feb; 23(2 PT. 1):241-4. PubMed ID: 318942 [TBL] [Abstract][Full Text] [Related]
11. Validity testing of commercial urine cocaine metabolite assays: I. Assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans. Cone EJ; Menchen SL; Paul BD; Mell LD; Mitchell J J Forensic Sci; 1989 Jan; 34(1):15-31. PubMed ID: 2918277 [TBL] [Abstract][Full Text] [Related]
12. Occupational exposure to cocaine involving crime lab personnel. Le SD; Taylor RW; Vidal D; Lovas JJ; Ting E J Forensic Sci; 1992 Jul; 37(4):959-68. PubMed ID: 1506838 [TBL] [Abstract][Full Text] [Related]
14. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing. Preston KL; Huestis MA; Wong CJ; Umbricht A; Goldberger BA; Cone EJ J Anal Toxicol; 1999 Sep; 23(5):313-22. PubMed ID: 10488917 [TBL] [Abstract][Full Text] [Related]
15. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results. Cone EJ; Lange R; Darwin WD J Anal Toxicol; 1998 Oct; 22(6):460-73. PubMed ID: 9788521 [TBL] [Abstract][Full Text] [Related]
16. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis. Lewis DE; Moore CM; Leikin JB; Koller A J Anal Toxicol; 1995; 19(3):148-50. PubMed ID: 7564291 [TBL] [Abstract][Full Text] [Related]
17. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse. Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297 [TBL] [Abstract][Full Text] [Related]